Swot Analysis For Pharmasim

Pharmasim – Final Simulation Report
Team 12

Team Member: Rajvi Patel

Table of Contents
Introduction 2
Pricing 2
Advertising 4
Sales force 8
Promotion 10
Segmentation 12
Product life cycle 13
Line extensions 14
Cumulative net income & final stock price 15
Conclusion & Future Forecast 16
References 17
Key Success Factors 17

Table of Figures
Figure 1 Comparison of Manufacturer Suggested Price for different brands 4
Figure 2 Advertising Expenditures for Allstar products through Period 0 to Period 10 5

Introduction
Team 12 reached its goals established in the initial strategy report by achieving a cumulative net income of $1,414 M and a stock price of $203.16. Team 12 was also achieved in percentage share of manufacturer’s sales

Allstar Brands' Allround product is a market leader in the over the-counter (OTC) cold and allergy remedy market” Allstar’s goal is to maintain its position as the market leader in over the counter (OTC) medicine by maintain long term profitability, increase in sales and marketshare. Allstar‘s goal is to dominate the competitive nature of the OTC cold remedy market. Allrounds direct competitors are B&B Health Care, Curall Pharmaceuticals, Driscol Corporation, and Ethik Incorporated. Allstar key marketing strategy is to develop a new product and integrate into the other segments. Allstar can acquire one of its competitors to increase market share. As it pertains to pricing, competitors are likely to be in command of the same intelligence, Allstar would anticipate them to potentially lower their price, produce a multi-symptom product, and change their formulation to be more in line with the trends r. Effective countermeasures would include, for price reductions, do nothing and wait to see if there is a change in market share as we are the price setter for this market or develop a new product in a different segment with favorable pricing. If Allstar introduced a newly reformulated multi-symptom product or new product in a different segment that addresses current trends, we would retain our market share and pricing lead at the very least and if they do not address the trends we

4 Ps Action Plan:
Place, we are in all the retail outlets and have maximized consumer accessibility in reference to geographic availability. We also have a well-developed distribution channel. Despite these advantages we are not being placed in the optimal locations within the retail stores. We should add Merchandisers to improve shelf placement within the retail locations.
Promotion, we have a solid advertising presence and brand recognition with the consumer. We have coupons via newspaper and magazine. We have POPs displays in retail locations. We should offer trial sizes to doctors who will be dealing with a significant percentage of those who will have symptoms. Product, we have the broadest symptom coverage. But we could offer a different formulation that is less sedative as well as a different delivery method such as capsules. Price, we enjoy high product effectiveness, brand recognition and consistent loyalty allowing us to be a pricing leader. The OMC group believes these factors have not hurt our sales despite our higher pricing.
Year One Financial Projections:
For introduction of new product, it can be developed